Kymanox

This October, in honor of 𝐁𝐫𝐞𝐚𝐬𝐭 𝐂𝐚𝐧𝐜𝐞𝐫 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐌𝐨𝐧𝐭𝐡, Kymanox is thrilled to partner with the Kay Yow Cancer Fund to support the fight against 𝐀𝐋𝐋 women’s cancers! 💗 As of today, we have 7,070 followers, and for every new follower we gain throughout the month of October, Kymanox will donate $1 to the Kay Yow Cancer Fund, up to $3,000. Your support will help fund life-saving cancer research and provide access to healthcare for underserved women affected by cancer. Help us reach our goal to raise $3,000 for this incredible cause! 𝐇𝐞𝐫𝐞’𝐬 𝐡𝐨𝐰 𝐲𝐨𝐮 𝐜𝐚𝐧 𝐦𝐚𝐤𝐞 𝐚𝐧 𝐢𝐦𝐩𝐚𝐜𝐭:  1️⃣ Follow Kymanox on LinkedIn 2️⃣ Share this post to spread the word 3️⃣ Encourage your network to follow us too! Together, we can make a real difference in the fight against cancer. Join us today and be part of something amazing! 🙌 #breastcancerawareness #cancerresearch Terms & Conditions: Up to $3,000 total donation; valid for new followers from October 1–31, 2024.

We are delighted to announce that this year's recipient of the Swiss Army Knife Sage Award is Callie Halchin! This award celebrates an individual who demonstrates remarkable versatility in their skills and abilities. Callie's capacity to adapt and excel across various roles and challenges has been truly impressive. As singer-songwriter Wendy Starland aptly said, "My strength is in my ability to be versatile." Callie embodies this principle, bringing a diverse set of talents to bear on every task and project she undertakes. Please join us in congratulating Callie on receiving the Swiss Army Knife Sage Award!

What’s the Buzz?! The Hyper-Virtual Model in Philadelphia Join us LIVE on LinkedIn on 16 OCT, at 12:00 PM for an exciting event featuring Alexis Dechelette, PhD, Director of the Design and Innovation, and Chris Frew, CEO of BioBuzz Networks. They will discuss Kymanox’s Hyper-Virtual Model™ and its remarkable growth across Greater Philadelphia and the industry. Hear about impactful local projects, focusing on the challenges solved and the results achieved. Explore how the Philly expansion boosts Kymanox’s Hyper-Virtual Model™, enhancing speed, flexibility, and remote collaboration, while shaping the future for product start-ups and driving innovation in the biopharma industry. --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐊𝐲𝐦𝐚𝐧𝐨𝐱: Follow Us: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv https://lnkd.in/e6CiQPVj

In just two weeks, we'll be joining the largest gathering of pre-filled syringe and injection device experts at the PDA - Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference, in Phoenix, AZ. What to expect from Kymanox at PDA Universe 2024: 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧𝐬: "Disruptive Obesity Drugs and Delivery" by Mathias Romacker | 23 Oct, 13:00 "Too Much Innovation in Drug Delivery Devices?" by Andrew King | 23 Oct, morning 𝐄𝐱𝐩𝐞𝐫𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬: Visit us at Booth #810 to learn the latest trends in injectable delivery, device design, and regulatory strategies. 𝐍𝐞𝐭𝐰𝐨𝐫𝐤𝐢𝐧𝐠: Connect with our specialists on your pre-filled syringe and injection device projects. Lisa Yargeau, Matt Neighoff, Taras Seniuch From obesity treatments to practical device innovation, we're here to accelerate your success. Learn more: https://lnkd.in/eRdfCpzJ --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐊𝐲𝐦𝐚𝐧𝐨𝐱: Follow Us: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv

We were just featured in ONdrugDelivery Issue 166! Don’t miss our roundtable discussion, https://lnkd.in/e4Hrth-n, on the transformative potential of GLP-1 therapies with Kymanox CEO Stephen M. Perry, Mathias Romacker (Kymanox Executive Advisor), and Andreas Schneider (Ypsomed).  GLP-1s are changing the entire healthcare landscape, and staying informed on this topic is critical for anyone in the drug development and delivery space. In this conversation, they cover everything from the growing market potential of GLP-1s to the challenges and opportunities in creating connected, patient-centric delivery systems. Read the full article here: https://lnkd.in/e4Hrth-n #drugdelivery #glp1s

Rare Disease Targeting and Novel Therapy Delivery: 𝗔 𝗖𝗼𝗻𝘃𝗲𝗿𝘀𝗮𝘁𝗶𝗼𝗻 𝘄𝗶𝘁𝗵 𝗘𝘃𝗮𝗻 𝗘𝗱𝘄𝗮𝗿𝗱𝘀. "At Kymanox, we help companies determine the best platform for their candidate and ensure it achieves clinical outcomes while being safe for end users." In a recent insightful discussion on "Supplier Horizons" at Drug Delivery Leader, Evan Edwards, President of Kymanox, shared his expert views on the evolving landscape of drug delivery systems. 𝗞𝗲𝘆 𝗵𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗶𝗻𝗰𝗹𝘂𝗱𝗲: 🔸 Trend towards self-administration, with more patients managing treatments at home 🔸 Rise of biologics and novel therapies, including cell and gene therapies 🔸 Increasing focus on user-friendly designs and human factors engineering Watch the full interview> https://lnkd.in/eRPrAsnW --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝: Follow Kymanox: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv

We are excited to announce that this year's recipient of the "Raising the Roof" En Fuego Sage Award is Sydney Weaver! This award recognizes an individual who consistently demonstrates an exceptional level of effort in meeting deadlines. Sydney's tireless dedication and ability to go above and beyond have set a new standard of excellence within our organization. As A.D. Posey brilliantly stated, "Don't just raise the bar… Raise the roof." Sydney has embodied this sentiment, not only meeting expectations but consistently surpassing them with fiery enthusiasm and determination. Please join us in congratulating Sydney on receiving the "Raising the Roof" En Fuego Sage Award!

We’re excited to sponsor the Blue Mountain Annual Conference, happening from 15-17 October. Join our team, including Brandon Patterson and Corey Marshall, as we dive into the latest insights on asset management and compliance for the life sciences industry. If you’re interested in attending and exploring how this event can benefit your operations, let’s connect to see if you qualify for a special discount code! And mark your calendar to join us on Thursday, 17 October, from 10:150 -11:30 AM for an interactive focus group with Kymanox, Blue Mountain, and CHA, where we'll explore how facilities engineers can maximize the benefits of BM RAM to enhance operational efficiency and compliance. Learn more>> https://lnkd.in/ez6JTVsG --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝: Follow Kymanox: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv

Only one more day until the upcoming webinar: "Lean Into Success: Smart Financial Moves for Thriving Startups" Join our CEO and Founder, Stephen M. Perry (Kymanox), along with Tyler Mizenko (Prendio/BioProcure, Inc.), and Marguerite Hutchinson (STORM Therapeutics Limited), for an insightful webinar on 03 October 2024, at 1:00 PM. In today’s challenging fundraising landscape, running a lean operation is crucial for early-stage startups. Learn how to extend your cash runway and make smarter financial decisions from top industry leaders. They’ll share real-world success stories and practical strategies for efficient budget management, creative fund allocation, and negotiating better deals—all without compromising growth or innovation. Register now and gain valuable insights to help your startup thrive! https://lnkd.in/efDq7k_Z --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝: Follow Kymanox: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv

Join Us at CPHI Milan Next Week! Our global team, including Taras Seniuch, Sian Eden, Bruno Čok, and Paul Jansen, will be there to engage with industry leaders. Dive into the future of pharma with us at CPHI Milan! 📍 Visit our booth at Stand 20H38, in the Packaging and Drug Delivery zone to discover how Kymanox’s expertise can empower your journey in the pharma landscape. We offer tailored solutions to elevate your business. Don't miss this opportunity to connect and explore the latest innovations in the industry. See you there! --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝: Follow Kymanox: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv